Protease inhibitors. Part 7 (Q58863337)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699384%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Protease inhibitors. Part 7. Inhibition of Clostridium histolyticum collagenase with sulfonylated derivatives of L-valine hydroxamate (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699384%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699384%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Supuran CT

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699384%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699384%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmaceutical Sciences

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699384%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699384%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699384%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

67-76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699384%20AND%20SRC:MED&resulttype=core&format=json

Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococi, enterococci and Clostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Hydroxamic acids as potent inhibitors of endothelin-converting enzyme from human bronchiolar smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Purification and separation of individual collagenases of Clostridium histolyticum using red dye ligand chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Characterization of the individual collagenases from Clostridium histolyticum

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Matrix metalloproteinase inhibitors in arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

New hydroxamate inhibitors of neurotensin-degrading enzymes. Synthesis and enzyme active-site recognition.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Inhibition of Clostridium histolyticum collagenases by phosphonamide peptide inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

The determination of enzyme inhibitor constants

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Inhibition of the collagenase from Clostridium histolyticum by phosphoric and phosphonic amides

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Bis-substituted malonic acid hydroxamate derivatives as inhibitors of human neutrophil collagenase (MMP8).

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Aldehyde and ketone substrate analogues inhibit the collagenase of Clostridium histolyticum

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Dipeptide-hydroxamates are good inhibitors of the angiotensin I-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

How antibiotics cause antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Amino hydroxamic acids as potent inhibitors of leukotriene A4 hydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase of Escherichia coli is a zinc metalloenzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Sulfonamide-based hydroxamic acids as potent inhibitors of mouse macrophage metalloelastase

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

First hydroxamate inhibitors for carboxypeptidase A. N-acyl-N-hydroxy-beta-phenylalanines

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Matrix metalloproteinase inhibitors: a structure-activity study

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

A study of the collagen-binding domain of a 116-kDa Clostridium histolyticum collagenase

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Gene duplication and multiplicity of collagenases in Clostridium histolyticum.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Antibacterial agents that inhibit lipid A biosynthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Evolutionary families of metallopeptidases

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Virulence genes of Clostridium perfringens.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Carbonic Anhydrase Inhibitors. Synthesis of Water-Soluble, Topically Effective, Intraocular Pressure-Lowering Aromatic/Heterocyclic Sulfonamides Containing Cationic or Anionic Moieties: Is the Tail More Important than the Ring?1

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Carbonic Anhydrase Inhibitors: Synthesis of Water-Soluble, Aminoacyl/Dipeptidyl Sulfonamides Possessing Long-Lasting Intraocular Pressure-Lowering Properties via the Topical Route1

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Carbonic anhydrase inhibitors. Arylsulfonylureido- and arylureido-substituted aromatic and heterocyclic sulfonamides: towards selective inhibitors of carbonic anhydrase isozyme I

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Carbonic anhydrase inhibitors — Part 29 1: Interaction of isozymes I, II and IV with benzolamide-like derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Carbonic anhydrase inhibitors - Part 49: Synthesis of substituted ureido and thioureido derivatives of aromatic/heterocyclic sulfonamides with increased affinities for isozyme I

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Carbonic anhydrase inhibitors. Part 71

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

A continuous spectrophotometric assay for Clostridium histolyticum collagenase

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Clostridium histolyticum collagenase: development of new thio ester, fluorogenic, and depsipeptide substrates and new inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

New thiol inhibitor of Achromobacter iophagus collagenase. Specificity of the enzyme's S3' subsite

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

New thiol inhibitors of Clostridium histolyticum collagenase. Importance of the P3' position

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

Phosphinic peptide analogues as potent inhibitors of Corynebacterium rathayii bacterial collagenase

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900090-1

7 January 2021

10.1016/S0928-0987(99)00090-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699384%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference